Who Will “Dance” Now? Biosimilars After Amgen v. Sandoz
Developers for biosimilars face not only stiff technical and manufacturing challenges, but [...]
Exhaustion Unleashed: Licensing, Patenting Strategy, and Litigation After Lexmark
This webinar will explore the significant ramifications of the recent [...]
Venue Transfers and Section 1400(b) After Heartland
This webinar gathers three savvy patent litigators with deep knowledge [...]
Pharma Lessons from the PTAB: Litigation and Prosecution
After a slow start, AIA challenges are now a frequent [...]
On-Sale Bar After Helsinn: What is the Scope?
How can a recent Federal Circuit opinion on the on-sale [...]
Global FRAND Update – Europe
This webinar will consider the impact of recent important judicial [...]
Push Forward Report
Push Forward Report
After Laches: Equitable Estoppel Redux?
The recent U.S. Supreme Court decision in SCA Hygiene v. First [...]
New Invention Disclosure Standard – Why Would I Care?
New Invention Disclosure Standard – Why Would I Care?
DTSA: One Year In
The federal law protecting trade secrets is celebrating its first [...]